Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
First clinical trials to diagnose and treat Alzheimer’s disease

First clinical trials to diagnose and treat Alzheimer’s disease

New evidence suggests that taking vitamin B supplements may help reduce risk of stroke

New evidence suggests that taking vitamin B supplements may help reduce risk of stroke

Promising early findings from Parkinson’s biomarker study

Promising early findings from Parkinson’s biomarker study

Viewpoints: WSJ says GOP 'kamikaze' defunding mission will not go well; taxing Medicare benefits; problems with Penn. State's wellness program

Viewpoints: WSJ says GOP 'kamikaze' defunding mission will not go well; taxing Medicare benefits; problems with Penn. State's wellness program

Florida Hospital and VTT of Finland collaborate to predict early onsets of Alzheimer's disease

Florida Hospital and VTT of Finland collaborate to predict early onsets of Alzheimer's disease

LSDF announces Proof of Concept grants to speed up promising health-related technologies

LSDF announces Proof of Concept grants to speed up promising health-related technologies

Study shows distinct molecular structures may predominate in brains of Alzheimer's patients

Study shows distinct molecular structures may predominate in brains of Alzheimer's patients

Brain atrophy leads to cognitive decline in T2DM people

Brain atrophy leads to cognitive decline in T2DM people

New Tailored Activity Program to ease troublesome symptoms of dementia

New Tailored Activity Program to ease troublesome symptoms of dementia

Researchers develop method to distinguish memory declines from memory disorders

Researchers develop method to distinguish memory declines from memory disorders

New HIV/AIDS vaccine candidate appears to clear AIDS-causing virus from body

New HIV/AIDS vaccine candidate appears to clear AIDS-causing virus from body

Study: People who get occasional migraines are more likely to be obese

Study: People who get occasional migraines are more likely to be obese

New technique provides better understanding of factors causing Smith-Lemli-Opitz Syndrome

New technique provides better understanding of factors causing Smith-Lemli-Opitz Syndrome

Professors receive 100,000 Euro from Hartwig Piepenbrock-DZNE for outstanding brain research

Professors receive 100,000 Euro from Hartwig Piepenbrock-DZNE for outstanding brain research

UK and US policies risk conscription into unwanted 'war against dementia'

UK and US policies risk conscription into unwanted 'war against dementia'

Study shows huge cost implications in getting injured patients to appropriate trauma hospitals

Study shows huge cost implications in getting injured patients to appropriate trauma hospitals

Researchers identify alterations in proteins responsible for RNA splicing in Alzheimer's

Researchers identify alterations in proteins responsible for RNA splicing in Alzheimer's

Weill Cornell Medical College gets $100M gift to launch Driving Discoveries, Changing Lives campaign

Weill Cornell Medical College gets $100M gift to launch Driving Discoveries, Changing Lives campaign

Degeneration of fornix in brain may provide clues to future cognitive decline in healthy old people

Degeneration of fornix in brain may provide clues to future cognitive decline in healthy old people

Avanir Pharmaceuticals, Wockhardt settle patent litigation related to NUEDEXTA capsules

Avanir Pharmaceuticals, Wockhardt settle patent litigation related to NUEDEXTA capsules

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.